Pennant Capital Management’s Evolent Health EVH Stock Holding History

Pennant Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,201,130	Closed	-$55.8M	–	47
2017 Q2	$55.8M	Sell	2,201,130 -641,891	-23%	-$15.4M	3.28%	13
2017 Q1	$63.4M	Buy	2,843,021 +81,300	+3%	+$1.56M	3%	17
2016 Q4	$40.9M	Buy	2,761,721 +660,274	+31%	+$13M	1.59%	30
2016 Q3	$51.7M	Buy	2,101,447 +764,850	+57%	+$17.9M	1.81%	27
2016 Q2	$25.7M	Sell	1,336,597 -24,550	-2%	-$337K	0.66%	34
2016 Q1	$14.4M	Buy	1,361,147 +478,318	+54%	+$4.94M	0.41%	32
2015 Q4	$10.7M	Buy	882,829 +123,599	+16%	+$1.82M	0.27%	36
2015 Q3	$12.1M	Buy	759,230 +134,230	+21%	+$2.62M	0.26%	33
2015 Q2	$12.2M	Buy	+625,000	New	+$11.7M	0.24%	36

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Pennant Capital Management's EVH Position: Q3 2017 in Review

Pennant Capital Management sold out of Evolent Health (EVH) in Q3 2017, closing a stake of 2,201,130 shares — an estimated $55.8M sold.

Pennant Capital Management first reported a position in EVH in Q2 2015 and held it in 9 quarters. The position peaked at $63.4M in Q1 2017. 166 funds tracked by Wall St. Rank hold EVH as of Q3 2017.

Pennant Capital Management reported no remaining Evolent Health position as of Q3 2017 after selling out during the quarter.
Pennant Capital Management sold 2,201,130 Evolent Health shares in Q3 2017, an estimated $55.8M.
Pennant Capital Management first reported a position in Evolent Health in Q2 2015 and held it in 9 quarters.
Pennant Capital Management's Evolent Health position peaked at $63.4M in Q1 2017.
166 funds tracked by Wall St. Rank held Evolent Health as of Q3 2017.

Based on Pennant Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.